THE fragile-X syndrome is the most frequent inherited form of mental retardation, with an incidence of 1 in 1,500 males. It is characterized by the presence of a fragile site at Xq27.3 induced in vitro by folate deprivation or by inhibitors of deoxynucleotide synthesis1. Its mode of inheritance is unusual for an X-linked trait, with incomplete penetrance in both males and females. Some phenotypically normal males transmit the mutation to all their daughters who rarely express any symptoms, but penetrance is high in sons and daughters of these carrier women2. Genetic and physical mapping of the Xq27-q28 region has confirmed that the disease locus is located at or very near the fragile site3–6. Hypotheses proposed to account for the abnormalities in the inheritance of the disease include sequence rearrangements by meiotic recombination1,7,8 or a mutation that affects reactivation of an inactive X chromosome during differentiation of female germ cells9,10. To detect such rearrangements, or methylation changes that may reflect a locally inactive X chromosome, we used pulsed-field gel analysis of DNA from fragile-X patients with probes close to the fragile-X locus. The probe Do33 (DXS465) detected abnormal patterns in fragile-X patients, but not in normal controls or in non-expressing male transmitters.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Nussbaum, R. L. & Ledbetter, D. H. A. Rev. Genet. 20, 109–145 (1986).
Sherman, S. L. Jacobs, P. A. Morton, N. E., Froster-Iskenius, U. & Howard-Peebles, P. N. Hum. Genet. 69, 289–299 (1985).
Oberlé, I. et al. Proc. natn. Acad Sci. U.S.A. 83, 1016–1020 (1986).
Suthers, G. K. et al. Science 246, 1298–1300 (1989).
Suthers, G. K. et al. Am. J. hum. Genet. 47, 187–195 (1990).
Rousseau, F. et al. Am. J. hum. Genet. 48, 108–116 (1991).
Pembrey, M. E., Winter, R. & Davies, K. Am. J. med. Genet. 21, 709–717 (1985).
Ledbetter, D. H., Ledbetter, S. A. & Nussbaum, R. L. Nature 324, 161–163 (1986).
Laird, C. D. Genetics 117, 587–599 (1987).
Laird, C. D., Lamb, M. M. & Thorne, J. L. Am. J. hum. Genet. 46, 696–719 (1990).
Warren, S. T. et al. Proc. natn. Acad Sci. U.S.A. 87, 3856–3860 (1989).
Suthers, G. K. et al. Am. J. hum. Genet. (in the press).
Bird, A. P. Trends Genet. 3, 342–347 (1987).
Southern, E. M., Anand, R., Brown, W. R. A. & Fletcher, D. S. Nucleic Acids Res. 15, 5925–5943 (1987).
About this article
Molecular Autism (2018)
Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism
Molecular Autism (2017)
MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith–Magenis and fragile X syndromes
European Journal of Human Genetics (2015)
European Journal of Human Genetics (2008)